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Summary: It is not certain whether chloroquine-induced pruritus is mainly attributable to the liberation of 
histamine, a powerful gastric acid secretagogue from mast cells, which may not be beneficial in peptic 
ulceration.  Therefore, the aim of this study was to find out whether chloroquine (CQ) can stimulate gastric 
acid secretion in the rat. Gastric acid output was measured by the continuous perfusion of rats stomachs under 
anaesthesia with normal saline at the rate of 1ml per minutes. Thirty albino rats were divided into five groups 
of six rats each.  Three groups had   intraperitoneal administration of the following; normal saline (1ml/kg; 
control), CQ (3mg/kg; test) and Histamine H2 receptor antagonist, Ranitidine (4mg/kg) following CQ 
administration respectively. The other two groups had subcutaneous administration of histamine (100mg/kg) 
alone and histamine following CQ administration respectively. The basal acid secretion, (4.71± 
0.05µmol/10mins) in a group of rats was not significantly increased in comparison with the peak acid output 
(p > 0.05) following normal saline administration (1ml/kg; i.p.). Administration of CQ in a second group 
significantly increased acid secretion to a peak of 7.2 ± 1.7µmol/10mins (p < 0.05). Ranitidine blocked CQ -
induced acid secretion in a third group. Histamine significantly increased acid secretion from control level of 
4.85 ± 0.14 µmol/10mins to 51.67 ± 5.07µmol/10mins (p < 0.001) in a fourth group, while CQ administered 
2mins after histamine administration significantly increased acid level from 4.72 ± 0.12µmol/10mins to peak 
at 20.63 ± 3.28µmol/10mins (p < 0.001) in a fifth group of rats. The peak acid output in the fifth group was 
significantly lower than that obtained with histamine alone. In conclusion, chloroquine is a weak stimulant of 
gastric acid secretion rats.  It inhibits histamine-stimulated acid secretion probably by occupying histamine 
H2-receptors in rats. 
 
 





Chloroquine, a 4-aminoquinoline 
derivative (Clark et al, 1992; Webster, 1992), is 
commonly used in the chemotherapy of malaria 
fever, and as an anti-inflammatory disease 
modifying agent in patients with rheumatoid 
arthritis   or systemic lupus erythematosus 
(Onigbogi et al, 2000). Chloroquine is highly 
effective against susceptible strains of 
plasmodium, producing a radical cure in 
susceptible faciparum malaria, but suppressive 
only for Plasmodium vivax and Plasmodium 
ovale (Clark et al, 1992).  
The use of anti-histamine following 
chloroquine administration to suppress 
chloroquine-induced pruritus experienced by a 
large proportion of black Africans (Ajayi et al, 
1991; Adebayo   et al, 1997) suggests that 
chloroquine stimulates the release of histamine.  
Evidence to support the release of histamine by 
chloroquine is in the fact that chloroquine 
produces venodilation which is mediated by 
histamine (Abiose et al, 1997). Histamine is a 
known powerful gastric acid secretagogue and 
evokes copious secretion of gastric acid from 
parietal cells by acting on H2 receptors 
(Garrison, 1992). However, only histamine H1 
receptor antagonists are prescribed with 
chloroquine and no histamine H2 receptor 
antagonists are given thus suggesting that the 
histamine released may not affect gastric acid 
secretion. This suggestion may be unfounded. 
Therefore, the aim of this study is to find out 
whether therapeutic dose of chloroquine can 
stimulate gastric acid secretion in rats and the 
probable mechanism by which this occurs.  
 
Materials and methods 
Thirty albino rats of Wistar strain 
weighing between 200 and 300grams were used 
for the study. The rats were deprived of food 18 
hours before the experiment but allowed free 
access to clean drinking water. The animals 
were divided into 5 groups, with each group 
consisting 6 animals. The gastric acid secretion 
was measured using the continuous perfusion 
method of Gosh and Schild (1958), modified by 
Amure and Ginsburg (1964). The animals were 





anaesthetized with 25% urethane (ethyl 
carbamate) at a dose 6ml/kg body weight. A 
tracheal canula was inserted via an incision on 
the neck to ensure normal breathing through out 
the course of the experiment. An abdominal 
incision through the linea alba was made to 
expose the stomach and a semitransection made 
at the junction of the pylorus with the 
duodenum. A pyloric canula was inserted and 
tied to collect gastric contents. An orogastric 
canula was inserted for perfusion of pre-
warmed (at temperature 370C) 0.9% normal 
saline (pH 7.00) at a rate of 1ml/minute using a 
perfusion pump. The animals were kept warm 




Gastric acid was collect via the pyloric 
canula at 10 minutes intervals. In order to 
determine acidity, 10ml of the stomach 
perfusate was titrated against 0.01M sodium 
hydroxide (NaOH) solution with 
phenolphthalein as indicator. Titrable acidity 
was expressed in micro(µ)mol/10mins. The 
peak acid output per hour was calculated by 
multiplying by 6 the rate of acid secretion in the 
one-sixth hour in which the secretion was the 
greatest (Davenport, 1997). The test drugs/ 
substances were used 60 minutes post surgery 
at what time a steady basal (control) acid 
secretion has been obtained. 
Animals in group 1 had normal saline 
(1ml/kg) injected intraperitoneally (i.p.) after a 
steady basal was obtained for one hour and the 
level of gastric acid secretion monitored. The 
animals in the second group were administered 
human therapeutic dose of chloroquine 
(3mg/kg) i.p. (Anigbogu and Badru, 2000) The 
third group of animals received Ranitidine 
(4mg/kg i.p.), a histamine H2 receptor blocker, 
followed by chloroquine. Histamine alone 
(100mg/kg) was administered subcutaneously 
(Ganong, 1997) to animals in the fourth group, 
while animals in the fifth group received 
histamine followed by chloroquine 




The effect of chloroquine and normal saline 
on gastric acid secretion in rats. 
A steady control (basal) level of acid 
secretion was obtained for about 60 minutes 
and afterwards the drugs administered. The 
mean basal acid output in group 1 (control 
group administered 1ml/kg normal saline, i.p.) 
was 4.71 ± 0.05µmol/10mins. On 
administration of normal saline, a peak acid 
output of 5.3 ± 0.5µmol/10mins was obtained. 
These values did not differ significantly. 
The mean basal acid output in the second 
group was 4.7 ± 0.47µmol/10mins. Twenty 
minutes after administration of chloroquine 
(3mg/kg, i.p.) the acid output rose significantly 
to a peak of 7.2 ± 1.2µmol/10mins (p<0.05). 
Even after some fluctuations in acid levels after 
chloroquine administration, the mean acid 
output (5.62 ± 0.81µmol/10mins) was still 
significantly higher than control. Figure 1 
shows a comparison between the effect of 
normal saline (1ml/kg) and chloroquine 
(3mg/kg) on gastric acid secretion. 
 
Effect of chloroquine alone and chloroquine 
plus ranitidine on gastric acid secretion in 
rats. 
In the third group of animals, the 
administration of CQ (3mg/kg) 2 minutes 
following ranitidine administration (4mg/kg, 
i.p.) showed a peak acid output of 5.5 ± 
1.33µmol/10mins which was not significantly 
different from the basal output of 4.61 ± 
0.04µmol/10mins. The peak acid output in this 
group (CQ + Ranitidine), 5.5 ± 
1.33µmol/10mins, was also not significantly 
different from that obtained from the CQ 
administered group, 7.2 ± 1.2µmol/10mins. 
Figure 2 compared the effect of CQ alone and  
CQ and Ranitidine on gastric acid secretion. 
This did not show any statistically significant 
difference. 
 
Effect of Histamine alone and Histamine + 
chloroquine on gastric acid output. 
Histamine(100mg/kg body wt) 
significantly increased acid output from basal 
level 4.85 ± 0.14µmol/10mins to a peak of 
51.67 ± 5.07µmol/10mins after 80minutes 
(P<0.001). However, when histamine was 
administered subcutaneously following 
intraperitoneal administration of CQ, the peak 
acid output was 20.67 ± 3.78 µmol/10mins, 
significantly higher than the steady basal 
secretion of 4.72 ± 0.12µmol/10mins 
(P<0.001). The peak acid output was however, 
lower than (P<0.001) the value obtained with 






















































































































Comparison of the effect of Normal saline, 
Chloroquine (CQ), CQ + Ranitidine, 
Histamine and Histamine + CQ on peak acid 
output. 
The peak acid output obtained from CQ 
(3mg/kg, i.p.) administered group was 7.2 ± 
1.2µmol/10mins and it was higher (P< 0.05) 
when compared to that obtained from the 
normal saline (1ml/kg, i.p.) administered group, 
which was 5.3 ± 0.05µmol/10mins (Control). 
The peak acid output obtained when ranitidine 
was administered 2minutes before CQ was 5.5 
± 1.33µmol/10mins and it was not significantly 
different from that obtained for control. When 
Histamine was administered alone, the peak 
acid output  was 51.67 ± 5.07µmol/10mins, 
which was significantly higher (P< 0.001) than 
control and CQ administered group. However, 
when Histamine was administered with CQ the 
peak acid output (20.63 ± 3.78µmol/10mins) 
decreased (P< 0.001) significantly, in 
comparison with histamine alone although it 
was still higher (P< 0.001) than control and CQ 
administered groups (Fig. 4). 
 
Fg. 4: Comparison of the effect of Normal saline, Chloroquine (CQ), CQ + Ranitidine, Histamineand 



































NS – Not significant in comparison with control, * = P< 0.05 in comparison with control group, 
*** = P< 0.001 in comparison with control group, !!! = P< 0.001 in compared with Histamine group. 






Intraperitoneal administration of human 
therapeutic dose of chloroquine in rats caused 
significant increase in the gastric acid secretion when 
compared to the acid output following normal saline 
administration that was used as control. It would 
appear that its effect may be due to histamine release 
since Ezeamuzie et al (1990) and Nosal et al (1991) 
reported the liberation of low amounts of histamine 
from isolated rat mast cells by chloroquine. 
However, another set of our experiments 
indicated that chloroquine effect on gastric acid 
secretion may not be due to histamine release. 
Subcutaneous administration of histamine stimulated 
a copious amount of acid in the rats which is in 
consonance with previous reports (Garrison, 1992). 
However, when histamine was administered 
subcutaneously following chloroquine administration 
intraperitoneally in another group of rats, there was 
also a significant increase in acid output compared 
with control levels. This increase was however, 
significantly lower than that obtained when only 
histamine was given. Chloroquine may therefore not 
stimulate acid secretion in the rat via histamine 
release since it did not potentiate histamine-
stimulated gastric acid secretion but reduced it. It is 
likely that chloroquine mechanism on acid secretion 
may be similar to that of cholecystokinin. 
Cholecystokinin, a weak gastric acid stimulant, 
competitively inhibits gastrin-stimulated acid 
secretion by occupying gastrin receptors and thereby 
denying them to the more potent hormone 
(Davenport, 1984). It is likely therefore, that 
chloroquine weakly stimulates acid secretion but 
competitively inhibits histamine-stimulated acid 
secretion by occupying the same histamine H2-
receptors. In support of chloroquine occupying 
Histamine H2-receptors, the administration of 
ranitidine, histamine H2 – receptor antagonist, two 
minutes before chloroquine administration resulted in 
a reduction of acid output comparable to the control 
level. The reduction in acid output following 
ranitidine administration suggests that chloroquine 
weakly stimulated acid secretion in the rats via its 
action on histamine H2 receptors. There is, however, 
the possibility of the involvement of other receptors, 
which were not investigated.  
In conclusion, chloroquine is a weak stimulant 
of gastric acid secretion, but it inhibits histamine 
stimulated acid secretion probably by occupying 
histamine H2-receptors. If these findings are 
extrapolated to man, chloroquine may therefore not 
be beneficial to peptic ulcer-prone individuals. 
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